Cargando…
Identification and validation of biomarkers based on cellular senescence in mild cognitive impairment
BACKGROUND: Mild cognitive impairment (MCI), a syndrome defined as decline of cognitive function greater than expected for an individual’s age and education level, occurs in up to 22.7% of elderly patients in United States, causing the heavy psychological and economic burdens to families and society...
Autores principales: | Ma, Songmei, Xia, Tong, Wang, Xinyi, Wang, Haiyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176455/ https://www.ncbi.nlm.nih.gov/pubmed/37187578 http://dx.doi.org/10.3389/fnagi.2023.1139789 |
Ejemplares similares
-
A novel predictive strategy for the incidence of postoperative neurocognitive dysfunction in elderly patients with mild cognitive impairment
por: Liang, Yueying, et al.
Publicado: (2022) -
A Deep Spatiotemporal Attention Network for Mild Cognitive Impairment Identification
por: Feng, Quan, et al.
Publicado: (2022) -
Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis
por: Ogonowski, Natalia, et al.
Publicado: (2022) -
Accurate module induced brain network construction for mild cognitive impairment identification with functional MRI
por: Du, Yue, et al.
Publicado: (2023) -
Acupuncture on mild cognitive impairment: A systematic review of neuroimaging studies
por: Yin, Zihan, et al.
Publicado: (2023)